WGU D027 - UNIT 6 QUESTIONS AND
ANSWERS WITH VERIFIED SOLUTIONS
2024
Core measures established by - ANSWER Centers for Medicare and Medicaid Services (CMS)
Core measure for controlling HTN - ANSWER 18-59 = <140/90
60-85 w/ DM = <140/90
60-85 w/o DM = <150/90
Core measures for bb tx after MI - ANSWER 18+, pt with AMI must receive bb for 6 months afterwards
Core measures for pt with ischemic vascular disease - ANSWER 18+ pt with AMI, CABG, PCI or dx of
ischemic vascular disease must take ASA or other antithrombotic
Core measures for comprehensive DM care - ANSWER - poor controlled HGA1C of >9.0%, should be
drawn at least yearly
- actual goal for someone with no comorbidities or glycemic risk is <6.5%
Core measures for medication reconciliation - ANSWER pt d/c from inpt facilities must have med
reconciliation within 30 days of d/c
Core measure for cervical cancer screening - ANSWER - women 21-64 = cervical cytology performed Q 3
yr
- women 30-64 = cervical cytology/HPV co-testing Q 5 yr
TJC national standard for quality measures that must meet the following strict requirements: - ANSWER -
Relate to pt safety or quality of care
- Positively impact healthcare outcomes
- Meet or surpass law and regulation
- Can be accurately and readily measured
ANSWERS WITH VERIFIED SOLUTIONS
2024
Core measures established by - ANSWER Centers for Medicare and Medicaid Services (CMS)
Core measure for controlling HTN - ANSWER 18-59 = <140/90
60-85 w/ DM = <140/90
60-85 w/o DM = <150/90
Core measures for bb tx after MI - ANSWER 18+, pt with AMI must receive bb for 6 months afterwards
Core measures for pt with ischemic vascular disease - ANSWER 18+ pt with AMI, CABG, PCI or dx of
ischemic vascular disease must take ASA or other antithrombotic
Core measures for comprehensive DM care - ANSWER - poor controlled HGA1C of >9.0%, should be
drawn at least yearly
- actual goal for someone with no comorbidities or glycemic risk is <6.5%
Core measures for medication reconciliation - ANSWER pt d/c from inpt facilities must have med
reconciliation within 30 days of d/c
Core measure for cervical cancer screening - ANSWER - women 21-64 = cervical cytology performed Q 3
yr
- women 30-64 = cervical cytology/HPV co-testing Q 5 yr
TJC national standard for quality measures that must meet the following strict requirements: - ANSWER -
Relate to pt safety or quality of care
- Positively impact healthcare outcomes
- Meet or surpass law and regulation
- Can be accurately and readily measured
